Difference between revisions of "CD10"

Jump to navigation Jump to search
34 bytes added ,  17:35, 20 March 2015
Line 2: Line 2:


==Positive==
==Positive==
*[[Clear cell renal cell carcinoma]].
===Benign===
*Benign liver.<ref name=pmid14755758/>
*Benign liver.<ref name=pmid14755758/>
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>


===Lymphoma===
===Lymphoma===
*[[Follicular lymphoma]].
*[[Follicular lymphoma]].
*[[Diffuse large B-cell lymphoma]].
*[[Diffuse large B-cell lymphoma]].
===Other tumours===
*[[Clear cell renal cell carcinoma]].
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>


==See also==
==See also==
48,536

edits

Navigation menu